. Author manuscript; available in PMC: 2013 Feb 1.

Published in final edited form as: Pharmacogenet Genomics. 2012 Feb;22(2):95–104. doi: 10.1097/FPC.0b013e32834dc9ef

Table 2.

Genotype Distribution and Association of CETP SNPs with T2D and CAD

T2D		Allele frequency NG (1,124)	Allele frequency T2D (1,307)	Odds Ratios^* (OR) (95%CI)
SNP	Allele	Allele frequency NG (1,124)	Allele frequency T2D (1,307)	Odds Ratios^* (OR) (95%CI)	p value
rs3764261	C/A	0.64/0.36	0.61/0.39	1.10 (1.0–1.3)	0.121
rs12447924	C/T	0.83/0.17	0.82/0.18	1.28 (0.8–2.0)	0.295
rs4783961	A/G	0.58/0.42	0.62/0.38	0.81 (0.7–1.0)	0.022^£
rs708272	A/G	0.5/0.5	0.52/0.48	0.89 (0.8–1.0)	0.054

CAD		Allele frequency Control (2,082)	Allele frequency CAD (349)	Odds Ratios^* (OR) (95%CI)
SNP	Allele	Allele frequency Control (2,082)	Allele frequency CAD (349)	Odds Ratios^* (OR) (95%CI)	p value

rs3764261	C/A	0.62/0.38	0.62/0.38	0.98 (0.8–1.2)	0.840
rs12447924	C/T	0.82/0.18	0.81/0.19	0.83 (0.4–1.6)	0.574
rs4783961	A/G	0.60/0.40	0.61/0.39	0.90 (0.7–1.2)	0.412
rs708272	A/G	0.51/0.49	0.53/0.47	0.84 (0.6–1.1)	0.244

ORs were adjusted for age and BMI;

^£

nonsignificant after Bonferroni’s correction